Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 63, , , . doi:
© 2009 American Association for Cancer Research

Right arrow Return to article

Table 2 Results of tissue array immunohistochemistry of 3439 individual tumors of >100 different types for POU5F1

The organ (in alphabetic order), tumor type, number of cases studied, and positive findings are indicated

Organ Tumor Subgroup n Positive

Adrenal gland Carcinoma Adeno- 19 0
Anus Carcinoma Squamous 3 0
Brain Gliobl. multif./astrocytoma/ 46/35 0
oligodendroglioma/meningioma/ 24/46 0
PNET/ependymoma/ 17/9 0
gangioneuroma/ 7 0
medulloblastoma/estioneuroblastoma/ 4/2 0
opticus glioma/cranioph.a 1/8 0
Carotid body Glomus tumor 11 0
Cervix Carcinoma Squamous/CIS/adeno 37/7/4 0
Colon Adenoma Tubular and villous 134 0
Carcinoma Adeno- 47 0
Endometrium Carcinoma Adeno- 61 0
Sarcoma Endometrial stromal sarcoma 3 0
Esophagus Carcinoma Squamous/adeno 21/116 0
Gall bladder Carcinoma Adeno- 23 0
Glomus tumor 11 0
Kidney Carcinoma Clear cell/papillary 50/45 1/0
Chromophobic 13 0
Oncocytoma 7 0
Larynx Carcinioma Squamous 46 0
Liver Carcinoma Hepatocellular 41 0
Lung Carcinoma Adeno-/squamous/ 48/50 0/1
large cell/small cell 47/41 1/0
Lymph nodes Lymphoma Hodgkin’s 50 0
Non-Hodgkin’s high/low grade 69 0
MALT 42 0
Breast Carcinoma Lobular/ductal 42/46 0
Med./muc./tub. 27/23/26 0
Cribriform/apocrine 5/3 0
Phylloidees tumor 13 0
Mouth Carcinoma Squamous 57 0
Ovary Carcinoma Endometroid/serous mucinous 49/48/20 0
Brenner/mixed Müllerian tumor 9/6 0
Granulosa cell 7 0
Dysgerminoma 2 2
Gonadoblastoma 1 1
Pancreas Carcinoma Adeno- 47 0
Paraganglia Paraganglioma 10 0
Parathyroid Carcinoma Adeno- 20 0
Parotid gland Carcinoma Mixed 15 0
Acinic cell/mucoepithelial 5/6 0
Phaeochrom. 26 0
Penis Carcinoma Squamous 43 0
Prostate Carcinoma Adeno-, horm. (non-)refract. 200 0
PIN/BPH 24/18 0
(Small) salivary gland Pleom. adenoma 49 0
Lymphoep. lesion 5 0
Carcinoma Adenoid cystic 43 0
Acinic cell 36 0
Adenolymph. 30 0
Skin Carcinoma Squamous/basal 81/37 0
Melanoma 44 0
Merkel cell tumor 6 0
Benign Hemangioblastoma 8 0
Nevus 38 0
Appendix tumors 25 0
(Small) intestine Carcinoma Adeno- 17 0
GIST 14 0
Stomach Carcinoma Intestinal/diffuse 44/23 0
Soft tissue Benign Lipoma/fibrous histiocytoma/Schwann/ 15/58/35 0
neurofibroma/leiomyoblastoma/ 31/7 0
giant cell tumors of tendon sheet/ 29/ 0
hemangioma 17 0
Intermediate Haemangiopericytoma 8 0
Dermatofibrosarcoma protuberans 2 0
Malignant Kaposi/liposarcoma 25/26 0
Angiomyolipo./malign. Schwann. 1/8 0
Rhabdomyosarcoma/synovial sarcoma 13/3 0
Angios./fibros./alv. soft part sarc. 4/6/1 0
Epithelioid sarcoma 2 0
Testis Seminoma/nonseminoma 49/47 49/33b
Adenomatoid tumor 10 0
Thyroid Carcinoma Foll./papill./med. 42/48/36 0
Thymus Thymoma 23 0
Urinary bladder Carcinoma TCC 101 0
Small cell/squamous/adeno- 3/5/4 0
Sarcoma 7 0
Uterus Myoma 107 0
Vagina Carcinoma Squamous 5 0
Vulva Carcinoma Squamous 37 0
Various Carcinoid 48 0
Adenomatoid tumor 10 0
Mesothelioma 23 0
Controlsc 30 0

a Gliob. multif., glioblastoma multiforme; PNET, primitive neuro-ectodermal tumor; cranioph, craniopharyngioma; CIS, carcinoma in situ; MALT, mucosa associated lymphoid tissue; med, medullar; muc, mucinous; tub, tubular; horm (non-)refract, hormonal (non)refractory; angiomyolipo., angiomyoliposarcoma; malign. Schwann., malignant Schwannoma; anglo., angiosarcoma; fibros., fibrosarcoma; alv. soft part sarc., alveolar soft part sarcoma; foll., follical.

b If containing seminoma in case of combined tumors or embryonal carcinoma elements.

c Included in all seven slides: skin (n = 4); lymph node (n = 2); heart (n = 2); skeletal muscle (n = 2); smooth muscle (n = 2); myometrium (n = 2); thyroid gland (n = 2); liver (n = 2); kidney cortex (n = 2); prostate (n = 2); testis (n = 2); submand. gland (n = 2); proliferative endometrium (n = 2); gray matter cerebrum (n = 2).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online